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Introduction 
 
 The heavy metal pollution due to their industrial production, waste repository or accident as 
the cyanide spill in river Tisza in 2002, increase the scientific interest for using an ideal trace isotope 
for monitoring these type of events. Lead is one of the most toxic and commonly used heavy metal, its 
poisoning is often deadly because very difficult to recognize and identify. The neuro-scientific study of 
biodegradation effect of lead could be an impressive scientific field of application of 
203
Pb 
radioisotope. Furthermore, the targeted radionuclide therapy via-emitting radioisotopes is also of 
interest and employed tracers such as 
213
Bi and 
212
Pb [1,2]. Therefore 
203
Pb is a potential radioisotope 
for this role due to its -radiation and as heavy metal element to trace the therapy. 
 
Experiment 
 
 The production of 
203
Pb was carried out from metal  
nat
Tl by the 
 
nuclear reaction  of 
203
Tl(p,n)
203
Pb with proton beam 14.5 MeV energy and beam current of 5 As. The irradiation time 
was 18 hours and the produced activity was 80 MBq at EOB. The irradiated Thallium was dissolved in 
mix of diluted nitric and chloric acid. The excess acid was evaporated slowly. The nitrate form was 
transferred to chloride form by 8 mol/dm
3
 HCl and the Thallium was kept in 3+ oxidation stage by 
hydrogen peroxide. The separation was carried out on the anion exchange column (DOWEX 1x4, 
200/400 mesh, 15 cm long and 0.5 cm i.d.) in 8 mol/dm
3
 HCl media, based on literature [3]. The 
radioactive 
203
Pb was collected in the effluent. The target material Tl remained on the column. The 
regeneration of the column, i.e. collection of Thallium was made by washing of the column with 
deionized water. The collected fraction of 
203
Pb was evaporated to wet dryness and take back with 
saline of 0.8 ml.  
  
Results 
 
The separation yield was 63%+12%, corrected by decay. Due to the necessary longer cooling time (1 
day, approximately) and the time-consuming separation the chemical yield is low. At the same time, no 
contaminating radioisotopes were detected in the product as can be seen  in Fig. 1. 
 
Fig.1.: Gamma-spectrum of separated 
203
Pb 
The amount of Tl in the end-product was 7 g, which is much less than the tolerable level for the mice 
[4]. The specific activity of 
203
Pb was determined by ICP-MS, which is 7,2 Ci/mmol. The stock 
solution of 
203
Pb with above mentioned quality is ready to use in nuclear medicine for labelling as well 
as for  SPET- diagnosis of bone tumours. 
 
Conclusion 
The 
203
Pb radioisotope with high specific activity was successfully produced by the 
nat
Tl(p,n)
203
Pb 
nuclear reaction in reasonable amount (1mCi) for the preliminary animal experiment ( I. phase) in  
nuclear medicine, as trace radioisotope for emitter radionuclid therapy
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